Medicare Enrolled
Dr. Satinderpaul Satia, M.D.
Interventional Pain Medicine Physician · Sarasota, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Satia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Satia? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Satia
Dr. Satinderpaul Satia is an interventional pain medicine physician in Sarasota, FL, with 18 years in practice. Based on federal Medicare data, Dr. Satia performed 44,856 Medicare services across 5,083 unique beneficiaries.
Between the years covered by Open Payments, Dr. Satia received a total of $15,521 from 74 pharmaceutical and/or device companies across 549 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional pain medicine physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Satia is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 3% volume in FL$ $15,521 industry payments
Medicare Practice Summary
Medicare Utilization ↗44,856
Medicare services
Top 3% in FL for interventional pain medicine physician
5,083
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,492 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging, lower concentration | 25,700 | $0 | $1 |
| Dexamethasone injection (steroid) | 6,297 | $0 | $0 |
| Injection, propofol, 10 mg | 4,952 | $0 | $1 |
| Office visit, established patient (30-39 min) | 2,874 | $92 | $228 |
| Injection, fentanyl citrate, 0.1 mg | 845 | $1 | $2 |
| Office visit, established patient (20-29 min) | 838 | $66 | $151 |
| New patient office visit (45-59 min) | 339 | $122 | $353 |
| Injection, methylprednisolone acetate, 40 mg | 326 | $6 | $11 |
| Physical therapy exercise, per 15 min | 272 | $18 | $69 |
| Destruction of peripheral nerve or branch | 214 | $118 | $345 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 212 | $207 | $580 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 168 | $184 | $455 |
| Injection of substance into lower spine canal using imaging guidance | 160 | $190 | $608 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 158 | $99 | $225 |
| New patient office visit (30-44 min) | 146 | $80 | $229 |
| Injection, midazolam hydrochloride, per 1 mg | 122 | $0 | $1 |
| Injection, ketorolac tromethamine, per 15 mg | 106 | $0 | $2 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 99 | $190 | $505 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 98 | $94 | $230 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 96 | $460 | $1,015 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 94 | $260 | $435 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 92 | $99 | $245 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 83 | $141 | $425 |
| Joint injection, major joint | 77 | $43 | $176 |
| Ultrasonic guidance for needle placement | 72 | $45 | $505 |
| Blood glucose (sugar) test performed by hand-held instrument | 47 | $3 | $8 |
| Destruction of nerves supplying joint between spine and pelvis using imaging guidance | 38 | $434 | $1,305 |
| Injection of substance into middle or upper spine canal using imaging guidance | 35 | $202 | $621 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 33 | $454 | $1,035 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 32 | $270 | $465 |
| X-ray of lower and sacral spine, minimum of 4 views | 31 | $39 | $131 |
| Injection of anesthetic agent and/or steroid into knee nerve branch using imaging guidance | 28 | $166 | $559 |
| Telephone medical discussion with physician, 5-10 minutes | 26 | $43 | $91 |
| Office visit, established patient (10-19 min) | 25 | $42 | $91 |
| Destruction of nerve branches of knee using imaging guidance | 21 | $271 | $1,067 |
| Injection, methylprednisolone acetate, 80 mg | 18 | $10 | $16 |
| Heat destruction of intraosseous basivertebral nerve in bones of spine in lower back, first two bones | 16 | $335 | $1,211 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 15 | $53 | $205 |
| Drug injection, under skin or into muscle | 15 | $11 | $50 |
| Treatment of broken middle spine bone with placement of stabilizing device using imaging guidance | 12 | $4,377 | $19,000 |
| X-ray of lower and sacral spine, 2-3 views | 12 | $30 | $94 |
| Office visit, established patient, complex (40-54 min) | 12 | $133 | $309 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$15,521
Total received (2018-2024)
Avg $2,217/year across 7 years
Top 15% in FL for interventional pain medicine physician
74
Companies
549
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,447 (99.5%)
Other
Charitable contributions, space rental, and other categories
$75 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,324
2023$2,440
2022$2,888
2021$1,728
2020$738
2019$900
2018$3,503
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Nuvectra Corporation
$1,896
Abbott Laboratories
$1,401
ABBVIE INC.
$885
Relievant Medsystems, Inc.
$875
Collegium Pharmaceutical, Inc.
$824
Boston Scientific Corporation
$765
PFIZER INC.
$673
Pacira Pharmaceuticals Incorporated
$650
AbbVie Inc.
$604
Nevro Corp.
$590
IBSA Pharma Inc.
$443
Amgen Inc.
$431
Allergan, Inc.
$430
Biohaven Pharmaceuticals, Inc.
$371
Biohaven Pharmaceutical Holding Company Ltd.
$359
Almatica Pharma LLC
$308
Centinel Spine, LLC
$222
Flexion Therapeutics, Inc.
$211
GRT US Holding, Inc.
$206
Jazz Pharmaceuticals Inc.
$198
Teva Pharmaceuticals USA, Inc.
$185
Lilly USA, LLC
$174
Medtronic, Inc.
$173
BioDelivery Sciences International, Inc.
$153
Averitas Pharma Inc.
$149
Stimwave Technologies Incorporated
$146
EISAI INC.
$143
TerSera Therapeutics LLC
$140
IDORSIA PHARMACEUTICALS US INC
$133
Ipsen Biopharmaceuticals, Inc
$118
Novartis Pharmaceuticals Corporation
$109
Scilex Pharmaceuticals Inc.
$94
Allergan Inc.
$84
Horizon Therapeutics plc
$77
Baxter Healthcare
$75
Merz Pharmaceuticals, LLC
$73
Ferring Pharmaceuticals Inc.
$69
Avanos Medical
$68
Medtronic USA, Inc.
$58
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$50
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$47
Daiichi Sankyo Inc.
$47
Egalet US Inc
$46
BOSTON SCIENTIFIC CORPORATION
$42
Azurity Pharmaceuticals, Inc.
$38
RedHill Biopharma Inc.
$37
ARBOR PHARMACEUTICALS, INC.
$33
ASSERTIO THERAPEUTICS, Inc.
$32
INSYS Therapeutics Inc
$32
Nalu Medical, Inc.
$31
Assertio Therapeutics, Inc.
$29
Flowonix Medical Incorporated
$29
Kowa Pharmaceuticals America, Inc.
$28
Fidia Pharma USA Inc.
$28
Takeda Pharmaceuticals U.S.A., Inc.
$28
DePuy Synthes Sales Inc.
$25
Bioventus LLC
$24
SCILEX PHARMACEUTICALS INC.
$24
Vertos Medical, Inc.
$24
West Therapeutics Development, LLC
$23
SPR Therapeutics, Inc
$23
Trevena, Inc.
$22
Stryker Corporation
$22
Electronic Waveform Lab, Inc.
$22
Saluda Medical Americas, Inc.
$21
PROTEGA PHARMACEUTIALS LLC
$20
Lundbeck LLC
$19
ICU Medical Inc
$19
Orthogenrx Inc.
$18
MVP Orthopedics Inc
$18
Kaleo, Inc.
$17
Purdue Pharma L.P.
$13
MDD US Operations, LLC
$12
Zyla Life Sciences
$12
Top 3 companies account for 26.9% of total payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · AMITIZA · ARYMO ER · Aimovig · Algovita · Amitiza · BELBUCA · BOTOX · BOTOX THERAPEUTIC · BUNAVAIL 2.1 mg 30-count box · Cambia · DUEXIS · DUROLANE · DYSPORT · Dayvigo · EMGALITY · EUFLEXXA · EVENITY · Evoke · Evzio · Exparel · FORTEO · GENERAL PAIN MANAGEMENT · GENERATOR · GRALISE · General - Vascular Access · Gralise · HYMOVIS · Horizant · INTELLIS · INTELLIS ADAPTIVESTIM · IVS - MULTIGEN 2RF · Intracept · Iovera · LICART · LUCEMYRA · LYRICA · Lazanda · Licart · MONOVISC · MYOBLOC · Morphabond ER · Movantik · NAPRELAN · NURTEC ODT · Nalu Neurostimulation System · OLINVYK · Omnia · PAXLOVID · PENNSAID · PRIALT · PROCLAIM · PRODIGY · PRODISC C · PRODISC C VIVO · Pain Trays · Prialt · Prolia · Prometra II · QULIPTA · QUTENZA · QUVIVIQ · Qutenza · RELISTOR · RELISTOR ORAL · REYVOW · Roxybond · SPRINT PNS System · SPRIX · SUBSYS · SYMPROIC · SYNDROS · Seglentis · Senza · Senza Spinal Cord Stimulation System · TRIVISC SODIUM HYALURONATE · Tirosint · TriVisc sodium hyaluronate · UBRELVY · VRAYLAR · VYEPTI · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · Xeomin · Xtampza ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $35 per 100 Medicare services performed
Geographic Context
Interventional Pain Medicine Physicians within 10 mi
16
Per 100K population
3.6
County median income
$80,633
Nearest hospital
HCA FLORIDA SARASOTA DOCTORS HOSPITAL
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Satia is a mixed practice specialist, with above-average Medicare volume (top 3% in FL), and high industry engagement (low-engagement, top 15%), with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Satia experienced with contrast dye for imaging, lower concentration?
Based on Medicare claims data, Dr. Satia performed 25,700 contrast dye for imaging, lower concentration services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Satia receive payments from pharmaceutical companies?
Yes. Dr. Satia received a total of $15,521 from 74 companies across 549 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Satia's costs compare to other interventional pain medicine physicians in Sarasota?
Dr. Satia's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Satia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Pain Medicine Physicians in Sarasota
Browse interventional pain medicine physicians in Sarasota ranked by procedure volume and transparency data.
Highest volume
Top Interventional Pain Medicine Physicians in FL
Interventional Pain Medicine Physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Pain Medicine Physicians in FL
Which FL interventional pain medicine physicians receive the most from drug and device companies.
By company
Nuvectra Corporation Payments to Doctors
See all physicians who received payments from Nuvectra Corporation.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology